fazarabine has been researched along with Benign Neoplasms, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eyre, HJ; Selby, GB; Townsend, J; Upchurch, C | 1 |
| Driscoll, JS; Johns, DG; Plowman, J | 1 |
1 trial(s) available for fazarabine and Benign Neoplasms, Brain
| Article | Year |
|---|---|
A phase II evaluation of fazarabine in high-grade gliomas: a Southwest Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents; Astrocytoma; Azacitidine; Brain Neoplasms; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Southwestern United States; Treatment Failure | 1994 |
1 other study(ies) available for fazarabine and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Comparison of the activity of arabinosyl-5-azacytosine, arabinosyl cytosine, and 5-azacytidine against intracerebrally implanted L1210 leukemia.
Topics: Animals; Antineoplastic Agents; Azacitidine; Brain Neoplasms; Carmustine; Cytarabine; Leukemia L1210; Mice; Mice, Inbred Strains; Neoplasm Transplantation | 1985 |